Accenture and Aon have teamed up to promote the creation of apprenticeship programs across Houston. Photo via Getty Images

Much of the business world has operated under the belief that to enter the workforce, one must have a four-year degree. While this belief might be evolving naturally over recent years, two corporations have teamed up to move the needle even more and are launching a program that opens the hiring door much wider to promote a diversified workforce.

Last week, Accenture and Aon – with support from the Greater Houston Partnership — announced the launch of the Greater Houston Apprenticeship Network in Houston. The program aims to promote and support apprentice programs across companies in town. The duo has already rolled out similar programs across six cities in the United States and plans to create 500 new jobs by 2025.

The initiative began in 2016 in Chicago, where both Accenture and Aon were re-evaluating their workforce.

"It was a CEO to CEO initiative between Aon and Accenture," Mary Beth Gracy, Accenture Houston's managing director, tells InnovationMap. "We realized we could have more of an impact together than we could separately."

Both companies took inventory of their workforce and what jobs they had and established what positions could be adjusted to be suitable to non-traditional hires.

"We took a look at our talent to see if there are roles where we could create hiring that didn't require a four-year degree," says Dawn Spreeman-Heine, managing director of commercial risk solutions at Aon. "We felt like that would boost our diversity and create a more diverse talent pipeline. At the same time, it would hopefully address an issue we had with attrition."

The programs are substantially different from internships — which are short term, part time, and don't necessarily lead to permanent jobs. The apprentices hired through the program would serve one or two years of paid on-the-job training with a path to permanent employment.

With all the work the two institutions put into creating their own programs, it became apparent that a network of support between companies — as well as other players — to create an ecosystem, as Gracy says.

"In this case, the ecosystem is the employers and the apprentices themselves – as well as the educators we get our talent from and the nonprofit partners that help surface the candidates," Gracy explains. "This is an ecosystem play about strengthening our pipelines, communities, and job opportunities."

With the launch, five founding members have joined the Greater Houston Apprenticeship Network: Dow Chemical, Whorley, Texas Mutual Insurance, Amazon Web Services, and University of Texas MD Anderson Cancer Center. These companies have committed to creating apprenticeship positions within their institutions, as well as to promote the program to others.

As the initiative continues, interested companies can learn more online. The network is interested in bringing on companies of all sizes and across industries — whether a company wants to hire 100 apprentices or startup is looking to findjust one.

Gracy and Spreeman-Heine agree that — while the program was always intended to expand — the timing of the program launching in a time of economic growth amid the pandemic makes the plans even more relevant.

"Unfortunate events sometimes spur on some really great things. It's even more compelling now — and employers are hurting even more now trying to fill these roles," Spreeman-Heine says. "It's perfect timing."

The program hopes to bring more diverse workforces to Houston corporations — as well as eliminate the stigma of hiring non-four-year-degree employees.

"Nothing breeds success like success," Gracy says. "The more we have people come into these roles and be successful, then the more momentum that's going to build upon that."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”

Chevron enters the lithium market with major Texas land acquisition

to market

Chevron U.S.A., a subsidiary of Houston-based energy company Chevron, has taken its first big step toward establishing a commercial-scale lithium business.

Chevron acquired leaseholds totaling about 125,000 acres in Northeast Texas and southwest Arkansas from TerraVolta Resources and East Texas Natural Resources. The acreage contains a high amount of lithium, which Chevron plans to extract from brines produced from the subsurface.

Lithium-ion batteries are used in an array of technologies, such as smartwatches, e-bikes, pacemakers, and batteries for electric vehicles, according to Chevron. The International Energy Agency estimates lithium demand could grow more than 400 percent by 2040.

“This acquisition represents a strategic investment to support energy manufacturing and expand U.S.-based critical mineral supplies,” Jeff Gustavson, president of Chevron New Energies, said in a news release. “Establishing domestic and resilient lithium supply chains is essential not only to maintaining U.S. energy leadership but also to meeting the growing demand from customers.”

Rania Yacoub, corporate business development manager at Chevron New Energies, said that amid heightening demand, lithium is “one of the world’s most sought-after natural resources.”

“Chevron is looking to help meet that demand and drive U.S. energy competitiveness by sourcing lithium domestically,” Yacoub said.

---

This article originally appeared on EnergyCapital.